Skip to main content
. 2018 Apr 5;293(21):8264–8274. doi: 10.1074/jbc.RA118.002128

Figure 8.

Figure 8.

Modulators acting at sites other than the benzodiazepine site at WT and cysteine-substituted GABAA receptors are unaffected by DTT treatment. Before modulator effects were tested, the EC5–10 concentration of GABA was determined in each oocyte. Effects of 200 mm ethanol and 100 nm allopregnanolone were measured in WT and α1(K104C)β2γ2(D75C) GABAA receptors before (white symbols and bars) and after (dark symbols and bars) application of DTT with no significant changes being observed (two-way ANOVAs; 200 mm ethanol (F(3,43) = 0.031); 100 nm allopregnanolone (F(3,45) = 0.176). Each symbol represents the percent potentiation of the GABA EC5–10 seen in one oocyte, and each bar represents the mean percent potentiation. Error bars represent the S.E.